©The Author(s) 2026.
World J Gastroenterol. Jan 14, 2026; 32(2): 114057
Published online Jan 14, 2026. doi: 10.3748/wjg.v32.i2.114057
Published online Jan 14, 2026. doi: 10.3748/wjg.v32.i2.114057
Figure 3 Cedrol re-established intestinal barrier integrity in dextran sulfate sodium-induced colitis.
A: Characteristic alcian blue periodic acid-Schiff staining (× 100) and histogram of stained regions; B-D: Representative immunohistochemistry images (× 100) and statistical analysis of the average optical density for zonula occludens 1 (B), occludin (C), and claudin 1 (D). Data are expressed as mean ± SD (n = 6). aP < 0.05. bP < 0.01. dP < 0.0001. CE: Cedrol; DSS: Dextran sulfate sodium; AB-PAS: Alcian blue periodic acid-Schiff staining; AOD: Average optical density; ZO-1: Zonula occludens 1.
- Citation: Zhao YQ, Zhang Y, Qin Y, Zhang RY, Wang JP. Cedrol ameliorates ulcerative colitis via myeloid differentiation factor 2-mediated inflammation suppression, with barrier restoration and microbiota modulation. World J Gastroenterol 2026; 32(2): 114057
- URL: https://www.wjgnet.com/1007-9327/full/v32/i2/114057.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i2.114057